MAGEA9 and cervical cancer: This study aims to provide new ideas for early diagnosis and treatment of cervical cancer patients by exploring the expression of MAGE-A9 in cervical cancer tissues and peripheral blood mononuclear cells (PBMC) and its relationship with the clinic-pathological characteristics and prognosis of patients.